Bowen, Deborah J.Shinn, Eileen H.Gregrowski, SophieKimmick, GretchenDominici, Laura S.Frank, Elizabeth S.Smith, Karen LisaRocque, GabrielleRuddy, Kathryn J.Pollastro, TeriMelisko, MichelleBallinger, Tarah J.Fayanju, Oluwadamilola M.Wolff, Antonio C.2022-07-182022-07-182020-03Bowen DJ, Shinn EH, Gregrowski S, et al. Patient-reported outcomes in the Translational Breast Cancer Research Consortium. Cancer. 2020;126(5):922-930. doi:10.1002/cncr.32615https://hdl.handle.net/1805/29616Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.en-USPublisher PolicyBreast cancer consortiumBreast cancer treatmentClinical trialsPatient-reported outcomesTranslational clinical judgementsArticle